Griffin, Edward
Shirley, Gawain
Lee, Xin Ying
Awad, Susanne F.
Tyagi, Alok
Goadsby, Peter J.
Funding for this research was provided by:
H. Lundbeck A/S
Article History
Received: 22 December 2023
Accepted: 12 March 2024
First Online: 18 April 2024
Declarations
:
: Not applicable.
: Not applicable.
: Edward Griffin is an independent health economist contracted to H. Lundbeck A/S or one of its affiliates through Edward Griffin Consulting Ltd (UK).Gawain Shirley, Xin Ying Lee, and Susanne F. Awad are employees of H. Lundbeck A/S or one of its subsidiary companies.Alok Tyagi reports, over the last 36 months, participation on a Data Safety Monitoring Board or Advisory BoardĀ for Lundbeck.Peter J. Goadsby reports, over the last 36 months, grants from Celgene and Kallyope, and personal fees from Aeon Biopharma, AbbVie, Amgen, eNeura, CoolTech LLC, Dr Reddys, Eli-Lilly and Company, Epalex, Linpharma, Lundbeck, Man&Science, Novartis, Pfizer, Sanofi, Satsuma, Shiratronics, and Teva Pharmaceuticals, and personal fees for advice through Gerson Lehrman Group, Guidepoint, SAI Med Partners, Vector Metric, and fees for educational materials from CME Outfitters, and publishing royalties or fees from Massachusetts Medical Society, Oxford University Press, UptoDate and Wolters Kluwer, and a patent magnetic stimulation for headache (No. WO2016090333 A1) assigned to eNeura without fee.